Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of innovative treatments for cancer, central nervous system disorders and other unmet medical needs.
Our mission is to impact the health and wellness of patients with life-threatening and life-debilitating diseases.